Company Directory / research

Cyrus Therapeutics logo

PrivateFor profitresearchSouth Korea

Cyrus Therapeutics

Cyrus Therapeutics is a biotechnology company that discovers and develops molecule medicines to conquer chronic diseases.

Founded
2019
7 years ago
Staff
11-50
band, as listed
Followers
-
on LinkedIn
Funding
$39B
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

11-50 people: larger than 33% of companies with a size listed

Age

201919002026

7 years old.

Reach

No web traffic ranking listed.

What it does

BiotechnologyClinical TrialsMedicalPharmaceutical

Funding, as listed

$39B currency not stated

  • Rounds2
  • LatestSeries b, Jan 2022
  • Investors7

What the source datasets report. We have not watched these rounds ourselves.

Every detail we hold

Everything the source datasets list about Cyrus Therapeutics, field by field. Contact details are held but never shown.

The company

Name
Cyrus Therapeutics
Type
For profit
Status
Private
Founded
2019
Industry
research
Categories
Biotechnology, Clinical Trials, Medical, Pharmaceutical

Where

Country
South Korea
Markets
Asia-Pacific (APAC)

Size and reach

Staff band
11-50

Funding, as listed

Total
39,000,000,000 (currency not stated)
Rounds
2
Latest round
Series b
Latest round date
Jan 2022
Investors
7
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

Cyrus Therapeutics may be growing as it has secured a significant payment of ₩208 billion for its SOS1 inhibitor for cancer, indicating a substantial revenue influx from a licensing deal. This financial transaction suggests a successful monetization of the company's research and development efforts in the biotechnology and pharmaceutical industry. The deal with Yuhan also implies a level of confidence in Cyrus Therapeutics' product and its potential market value, which can be seen as a positive indicator of the company's business health and growth trajectory.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

research in South Korea.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 13,309 companies in South Korea and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.